Clinical Trial Update: A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Hydronidone capsules for chronic hepatitis B-related liver fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis B-related Liver Fibrosis

Drugs mentioned

• Hydronidone Capsules

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B-related Liver Fibrosis | Phase 2 | Status: RECRUITING